Literature DB >> 25220657

Survival trends in hypopharyngeal cancer: a population-based review.

J Robert Newman1, Timothy M Connolly, Elisa A Illing, Meredith L Kilgore, Julie L Locher, William R Carroll.   

Abstract

OBJECTIVES/HYPOTHESIS: Recent reviews of laryngeal cancer have detected a trend toward reduced survival, linked temporally to an abrupt change in treatment of these patients during the 1990s to nonsurgical regimens. Because organ preservation also is an important goal for hypopharyngeal cancer, we sought to determine treatment trends and survival data for patients with hypopharyngeal squamous cell carcinoma (SCC). STUDY
DESIGN: Retrospective cohort.
METHODS: Records of 6,647 patients with SCC of the hypopharynx between 1973 and 2003 were selected for review from the Surveillance, Epidemiology and End Results database, with comparison of 1973 to 1989 and 1990 to 2003 cohorts.
RESULTS: Overall 5-year survival rates for hypopharyngeal cancer have improved. Average survival of hypopharyngeal cancer patients increased to 41.3% in those diagnosed 1990 to 2003 from 37.5% in those diagnosed 1973 to 1989 (P < 0.0001). Since 1990, there is a trend toward treatment using radiation without surgery (43.1% increased to 52.1%), combined surgical and radiation therapy is relatively unchanged (43.6% to 41.8%), and fewer patients underwent surgery alone (14% reduced to 7.3%).
CONCLUSION: There has been a trend away from surgical therapy for hypopharyngeal SCC. In contrast to laryngeal cancer, survival for hypopharyngeal cancer has improved since 1990.
© 2014 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Hypopharyngeal cancer; SEER database; laryngeal cancer; squamous cell carcinoma; survival

Mesh:

Year:  2014        PMID: 25220657     DOI: 10.1002/lary.24915

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  52 in total

1.  Matched-pair analysis of patients with advanced hypopharyngeal cancer: surgery versus concomitant chemoradiotherapy.

Authors:  Shigemichi Iwae; Masato Fujii; Ryuichi Hayashi; Yasuhisa Hasegawa; Takashi Fujii; Kenji Okami; Akihiro Homma; Tetsuro Onitsuka; Takakuni Kato; Takenori Ogawa; Kyoichi Terao; Nobuya Monden; Naoki Otsuki; Hiroshi Nishino; Ichiro Ota; Yasushi Fujimoto; Kazuto Matsuura; Kazuyoshi Kawabata; Hidetoshi Matsui; Koichiro Yonezawa; Ken-Ichi Nibu
Journal:  Int J Clin Oncol       Date:  2017-06-17       Impact factor: 3.402

2.  A nomogram for predicting occult lymph node metastasis in early hypopharyngeal cancer with cN0.

Authors:  Xiaohui Yuan; Chi-Yao Hsueh; Ming Zhang; Lei Tao; Liang Zhou
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-02-10       Impact factor: 2.503

Review 3.  [Imaging of the head and neck region].

Authors:  M Lell; K Mantsopoulos; M Uder; W Wuest
Journal:  HNO       Date:  2016-03       Impact factor: 1.284

4.  The predictive value of MRI in detecting thyroid gland invasion in patients with advanced laryngeal or hypopharyngeal carcinoma.

Authors:  Peiliang Lin; Xiaoming Huang; Chushan Zheng; Qian Cai; Zhong Guan; Faya Liang; Yiqing Zheng
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-12       Impact factor: 2.503

5.  A Survival Analysis of Hypopharyngeal Cancer Patients: A Hospital-Cancer registry Based Study.

Authors:  Manigreeva Krishnatreya; Amal Chandra Kataki; Jagannath Dev Sharma; Nizara Baishya; Tashnin Rahman; Mouchumee Bhattcharyya; Ashok Kumar Das; Manoj Kalita
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-12-27

6.  Selective EP2 and Cox-2 inhibition suppresses cell migration by reversing epithelial-to-mesenchymal transition and Cox-2 overexpression and E-cadherin downregulation are implicated in neck metastasis of hypopharyngeal cancer.

Authors:  Yoshihiro Watanabe; Yorihisa Imanishi; Hiroyuki Ozawa; Koji Sakamoto; Ryoichi Fujii; Seiji Shigetomi; Noboru Habu; Kuninori Otsuka; Yoichiro Sato; Mariko Sekimizu; Fumihiro Ito; Yuichi Ikari; Shin Saito; Kaori Kameyama; Kaoru Ogawa
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

Review 7.  [Imaging of the head and neck region].

Authors:  M Lell; K Mantsopoulos; M Uder; W Wuest
Journal:  Radiologe       Date:  2016-02       Impact factor: 0.635

8.  Co-targeting PI3K/Akt and MAPK/ERK pathways leads to an enhanced antitumor effect on human hypopharyngeal squamous cell carcinoma.

Authors:  Xiaolin Peng; Yao Liu; Shan Zhu; Xin Peng; Hui Li; Wenhui Jiao; Peng Lin; Zhe Zhang; Yuling Qiu; Meihua Jin; Ran Wang; Dexin Kong
Journal:  J Cancer Res Clin Oncol       Date:  2019-10-16       Impact factor: 4.553

9.  GPR12 inhibits migration and promotes apoptosis in esophageal cancer and hypopharyngeal cancer cells.

Authors:  Minfa Zhang; Xiaoqi Yang; Shuai Chen; Wenming Jia; Xiaojie Ma; Juan Wang; Ye Qian; Dapeng Lei; Heng Liu; Xinliang Pan
Journal:  Thorac Cancer       Date:  2021-03-20       Impact factor: 3.500

10.  Results of the IROCA international clinical audit in prostate cancer radiotherapy at six comprehensive cancer centres.

Authors:  Carla Lopes de Castro; Magdalena Fundowicz; Alvar Roselló; Josep Jové; Letizia Deantonio; Artur Aguiar; Carla Pisani; Salvador Villà; Anna Boladeras; Ewelina Konstanty; Marta Kruszyna-Mochalska; Piotr Milecki; Diego Jurado-Bruggeman; Joana Lencart; Ignasi Modolell; Carles Muñoz-Montplet; Luisa Aliste; Maria Gloria Torras; Montserrat Puigdemont; Luísa Carvalho; Marco Krengli; Ferran Guedea; Julian Malicki
Journal:  Sci Rep       Date:  2021-06-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.